Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion type Assertion NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_head.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion description "[Taken together, our data demonstrate that downregulation of CXCL16 plays an important role in renal cancer development and progression, and that CXCL16 in RCC is an independent prognostic marker for better patient survival.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_provenance.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion evidence source_evidence_literature NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_provenance.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion SIO_000772 19070478 NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_provenance.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion wasDerivedFrom befree-20140225 NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_provenance.
- NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_assertion wasGeneratedBy ECO_0000203 NP325881.RAyX6bg0QjNCqS2zLv4uE72ZAFNarM4Ku0LynKR0JdYAA130_provenance.